SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
Authors:
Open Access
- 18 April 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 22 (7) , 3582-3594
Abstract
The suppressor of zest 12 (SUZ12), one of the core polycomb repressive complex 2 (PRC2) components, has increasingly appreciated as a key mediator during human tumorigenesis. However, its expression pattern and oncogenic roles in head and neck squamous cell carcinoma (HNSCC) remain largely unexplored yet. Here, we sought to determine its expression pattern, clinicopathological significance and biological roles in HNSCC. Through data mining and interrogation from multiple publicly available databases, our bioinformatics analyses revealed that SUZ12 mRNA was significantly overexpressed in multiple HNSCC patient cohorts. Moreover, SUZ12 protein was markedly up‐regulated in primary HNSCC samples from our patient cohort as assessed by immunohistochemical staining and its overexpression significantly associated with cervical node metastasis and reduced overall and disease‐free survival. In the 4‐nitroquinoline 1‐oxide (4NQO)‐induced HNSCC mouse model, increased SUZ12 immunostaining was observed along with disease progression from epithelial hyperplasia to squamous cell carcinoma in tongue. Furthermore, shRNA‐mediated SUZ12 knock‐down significantly inhibited cell proliferation, migration and invasion in HNSCC cells, and resulted in compromised tumour growth in vivo. Collectively, our data reveal that SUZ12 might serve as a putative oncogene by promoting cell proliferation, migration and invasion, and also a novel biomarker with diagnostic and prognostic significance for HNSCC.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20151561, BK20161564, BK20161024)
- National Natural Science Foundation of China (81572669, 81602378, 81602386)
This publication has 39 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell CarcinomaPLOS ONE, 2011
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerMolecular Cancer, 2011
- Bmi1 is essential in Twist1-induced epithelial–mesenchymal transitionNature Cell Biology, 2010
- Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem CellsMolecular Cell, 2010
- Mechanisms of Polycomb gene silencing: knowns and unknownsNature Reviews Molecular Cell Biology, 2009
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisBMC Cancer, 2009
- Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription FactorMolecular and Cellular Biology, 2008
- Transcriptomic dissection of tongue squamous cell carcinomaBMC Genomics, 2008
- Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysisOncogene, 2003